Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 March 2023
Labatec is a privately owned Swiss-based pharmaceutical company with more than
50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Leveraging our well-established Swiss brands and our extensive commercial network, we deliver healthcare solutions that meet the needs of our markets. We are a trusted partner for healthcare professionals, patients, and laboratory & pharmacy businesses.
NEWS
MEET WITH US
Medical Congresses & Conferences
-
31 to 01
September
2023SSR Rheumatology
Interlaken
-
22 to 23
September
2023SGU
Lausanne Switzerland
-
2 to 4
November
2023SwissAnaesthesia Congress
Beaulieu, Lausanne
-
29 to 1
December
2023GSASA-JFSPH Congress
Geneva
Partnering & Corporate Development Events
-
7 to 8
June
2023Jefferies Healthcare Conference
New York, USA
-
25 to 26
September
2023EuroPLX 83
Vienna, Austria
-
24 to 26
October
2023CPHI
Barcelona, Spain
-
6 to 8
November
2023BIO Europe Fall
Munich, Germany